Koch M C, Steinmeyer K, Lorenz C, Ricker K, Wolf F, Otto M, Zoll B, Lehmann-Horn F, Grzeschik K H, Jentsch T J
Medical Center for Human Genetics, Marburg University, Germany.
Science. 1992 Aug 7;257(5071):797-800. doi: 10.1126/science.1379744.
Autosomal recessive generalized myotonia (Becker's disease) (GM) and autosomal dominant myotonia congenita (Thomsen's disease) (MC) are characterized by skeletal muscle stiffness that is a result of muscle membrane hyperexcitability. For both diseases, alterations in muscle chloride or sodium currents or both have been observed. A complementary DNA for a human skeletal muscle chloride channel (CLC-1) was cloned, physically localized on chromosome 7, and linked to the T cell receptor beta (TCRB) locus. Tight linkage of these two loci to GM and MC was found in German families. An unusual restriction site in the CLC-1 locus in two GM families identified a mutation associated with that disease, a phenylalanine-to-cysteine substitution in putative transmembrane domain D8. This suggests that different mutations in CLC-1 may cause dominant or recessive myotonia.
常染色体隐性全身性肌强直(贝克尔病)(GM)和常染色体显性先天性肌强直(汤姆森病)(MC)的特征是骨骼肌僵硬,这是肌肉膜兴奋性过高的结果。对于这两种疾病,均已观察到肌肉氯离子或钠离子电流或两者的改变。已克隆出人类骨骼肌氯离子通道(CLC-1)的互补DNA,将其物理定位在7号染色体上,并与T细胞受体β(TCRB)基因座相连。在德国家庭中发现这两个基因座与GM和MC紧密连锁。在两个GM家族的CLC-1基因座中发现了一个不寻常的限制性位点,该位点确定了一个与该疾病相关的突变,即假定的跨膜结构域D8中的苯丙氨酸到半胱氨酸替代。这表明CLC-1中的不同突变可能导致显性或隐性肌强直。